Skip to content
Politically.com Search all
Menu

2026 · 3rd Quarter (July 1 - Sep 30)

LABORATORY CORPORATION OF AMERICA HOLDINGS

Filed by KELLEY DRYE & WARREN LLP.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-11-01 06:26:09 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 20, 2026
Income
$110,000.00
Expenses
Not reported
Filing UUID
19b87736-b1fe-499c-8253-5a4e4ed2d908
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 5582/S. 2355, the Patients Deserve Price Tags Act, H.R. 9393, the Lower Costs, More Transparency Act, and H.R. 9645, the Health Care Price Certainty for All Americans Act, provisions relating to lab test price transparency; Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development.

Literal federal measure citations: H.R. 5269, S. 2761, H.R. 5582, S. 2355, H.R. 9393, H.R. 9645

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.